124 related articles for article (PubMed ID: 36260485)
1. Circulating mitochondrial DNA is associated with anemia in newly diagnosed hematologic malignancies.
Yue L; Li YH; Ma RL; Niu JW; Cui HT; Sun Y; Yun ZM; Zhuo HL; Wan LM; Li SB; Zhang X; Wu CJ; Hu LD; Tan YX
Leuk Lymphoma; 2023 Jan; 64(1):178-187. PubMed ID: 36260485
[TBL] [Abstract][Full Text] [Related]
2. DNA binding to TLR9 expressed by red blood cells promotes innate immune activation and anemia.
Lam LKM; Murphy S; Kokkinaki D; Venosa A; Sherrill-Mix S; Casu C; Rivella S; Weiner A; Park J; Shin S; Vaughan AE; Hahn BH; Odom John AR; Meyer NJ; Hunter CA; Worthen GS; Mangalmurti NS
Sci Transl Med; 2021 Oct; 13(616):eabj1008. PubMed ID: 34669439
[TBL] [Abstract][Full Text] [Related]
3. Red Blood Cells Homeostatically Bind Mitochondrial DNA through TLR9 to Maintain Quiescence and to Prevent Lung Injury.
Hotz MJ; Qing D; Shashaty MGS; Zhang P; Faust H; Sondheimer N; Rivella S; Worthen GS; Mangalmurti NS
Am J Respir Crit Care Med; 2018 Feb; 197(4):470-480. PubMed ID: 29053005
[TBL] [Abstract][Full Text] [Related]
4. Increased level of free-circulating MtDNA in maintenance hemodialysis patients: Possible role in systemic inflammation.
Zhong XY; Guo Y; Fan Z
J Clin Lab Anal; 2022 Jul; 36(7):e24558. PubMed ID: 35708020
[TBL] [Abstract][Full Text] [Related]
5. Management of anemia in patients with hematologic malignancies.
Straus DJ
Oncology (Williston Park); 2006 Jul; 20(8 Suppl 6):8-11. PubMed ID: 16925104
[TBL] [Abstract][Full Text] [Related]
6. Epoetin alfa therapy for patients with hematologic malignancies and mild anemia.
Straus DJ
Clin Lymphoma; 2003 Aug; 4 Suppl 1():S13-7. PubMed ID: 14556671
[TBL] [Abstract][Full Text] [Related]
7. Epoetin alfa corrects anemia and improves quality of life in patients with hematologic malignancies receiving non-platinum chemotherapy.
Littlewood TJ; Nortier J; Rapoport B; Pawlicki M; de Wasch G; Vercammen E; Schuette W; Wils J; Freund M;
Hematol Oncol; 2003 Dec; 21(4):169-80. PubMed ID: 14735555
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic potential of circulating cell-free nuclear and mitochondrial DNA for several cancer types and nonmalignant diseases: A study on suspected cancer patients.
Sundquist K; Sundquist J; Hedelius A; Memon AA
Mol Carcinog; 2020 Dec; 59(12):1362-1370. PubMed ID: 33051887
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial DNA in human malignancy.
Penta JS; Johnson FM; Wachsman JT; Copeland WC
Mutat Res; 2001 May; 488(2):119-33. PubMed ID: 11344040
[TBL] [Abstract][Full Text] [Related]
10. Deciphering the genetic and epidemiological landscape of mitochondrial DNA abundance.
Hägg S; Jylhävä J; Wang Y; Czene K; Grassmann F
Hum Genet; 2021 Jun; 140(6):849-861. PubMed ID: 33385171
[TBL] [Abstract][Full Text] [Related]
11. Anemia of hematologic malignancies: what are the treatment options?
Ludwig H
Semin Oncol; 2002 Jun; 29(3 Suppl 8):45-54. PubMed ID: 12082654
[TBL] [Abstract][Full Text] [Related]
12. Intra-individual state-dependent comparison of plasma mitochondrial DNA copy number and IL-6 levels in patients with bipolar disorder.
Kageyama Y; Deguchi Y; Kasahara T; Tani M; Kuroda K; Inoue K; Kato T
J Affect Disord; 2022 Feb; 299():644-651. PubMed ID: 34715189
[TBL] [Abstract][Full Text] [Related]
13. Metabolic Reprogramming in Response to Alterations of Mitochondrial DNA and Mitochondrial Dysfunction in Gastric Adenocarcinoma.
Chang TC; Lee HT; Pan SC; Cho SH; Cheng C; Ou LH; Lin CI; Lin CS; Wei YH
Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163779
[TBL] [Abstract][Full Text] [Related]
14. [Study on serum erythropoietin levels in patients with hematologic malignancies].
Han B; Shi YK; Zhu J; He XH; Lin NJ; Li SL; Shen T
Zhonghua Xue Ye Xue Za Zhi; 2006 Aug; 27(8):543-5. PubMed ID: 17172129
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial DNA aberrations and pathophysiological implications in hematopoietic diseases, chronic inflammatory diseases, and cancers.
Kim HR; Won SJ; Fabian C; Kang MG; Szardenings M; Shin MG
Ann Lab Med; 2015 Jan; 35(1):1-14. PubMed ID: 25553274
[TBL] [Abstract][Full Text] [Related]
16. Quantification of cell-free circulating mitochondrial DNA copy number variation in hepatocellular carcinoma.
Yalçınkaya B; Tastekin D; Güzelbulut F; Akgoz M; Pençe S
Rev Assoc Med Bras (1992); 2022 Sep; 68(9):1161-1165. PubMed ID: 36228247
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial DNA Instability in Mammalian Cells.
Carvalho G; Repolês BM; Mendes I; Wanrooij PH
Antioxid Redox Signal; 2022 May; 36(13-15):885-905. PubMed ID: 34015960
[No Abstract] [Full Text] [Related]
18. Detection of cell-free, exosomal and whole blood mitochondrial DNA copy number in plasma or whole blood of patients with serous epithelial ovarian cancer.
Keserű JS; Soltész B; Lukács J; Márton É; Szilágyi-Bónizs M; Penyige A; Póka R; Nagy B
J Biotechnol; 2019 Jun; 298():76-81. PubMed ID: 31002856
[TBL] [Abstract][Full Text] [Related]
19. Red Blood Cell Deformability and Distribution Width in Patients with Hematologic Neoplasms.
Lee JM; Suh JS; Kim YK
Clin Lab; 2022 Oct; 68(10):. PubMed ID: 36250843
[TBL] [Abstract][Full Text] [Related]
20. Referrals for suspected hematologic malignancy: a survey of primary care physicians.
Abel GA; Friese CR; Neville BA; Wilson KM; Hastings BT; Earle CC; Keating NL; Richardson LC
Am J Hematol; 2012 Jun; 87(6):634-6. PubMed ID: 22473854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
